Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crispr Therapeutics AG (CRSP) vs LyondellBasell Industries NV (LYB) Price & Performance

Crispr Therapeutics AGTrade
LyondellBasell Industries NVTrade

Price performance (Past 24H)

Key statistics

Crispr Therapeutics AG vs LyondellBasell Industries NV — how do they compare? Crispr Therapeutics AG trades at $54.08 (market cap $5.23B), while LyondellBasell Industries NV trades at $63.98 (market cap $20.67B). The key difference: LyondellBasell Industries NV is far larger — about 4× Crispr Therapeutics AG's market cap, and LyondellBasell Industries NV pays a 6.44% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.

CRSPLYB
Market Cap
$5.23B$20.67B
Sector
HealthBasic Materials
52-Week High
$76.78$82.38
52-Week Low
$44.34$42.28
Enterprise Value
$3.65B$32.26B
Dividend Yield
6.44%

Returns comparison

Trailing returns across standard periods

About Crispr Therapeutics AG

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.

Read more on CRSP

About LyondellBasell Industries NV

LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.

Read more on LYB